Pegvisomant in acromegaly: why, when, how.
Colao
A
A
Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples, Naples, Italy.
Arnaldi
G
G
Beck-Peccoz
P
P
Cannavò
S
S
Cozzi
R
R
degli Uberti
E
E
De Marinis
L
L
De Menis
E
E
Ferone
D
D
Gasco
V
V
Giustina
A
A
Grottoli
S
S
Lombardi
G
G
Maffei
P
P
Martino
E
E
Minuto
F
F
Pivonello
R
R
Ghigo
E
E
D000172:Acromegaly / Q000188:drug therapy* / Q000503:physiopathology; D019382:Human Growth Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D010902:Pituitary Gland / Q000502:physiology
D019382:Human Growth Hormone; C406545:pegvisomant